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SPECIAL PRESENTATION
Diagnostic advances and trends in modern nephrology
At the end of World War II, nephrology existed less like an
organized discipline and more like a distant dream. Nephrolo-
gists were doctors with a particular insight into the unique and
vital role which the kidney and its diseases play in human
biology. There were no constraints on their geographical or
intellectual origins, and budding nephrologists could literally
come out of anywhere and frequently come from nowhere. If
one could generalize at all, many of the better clinicians had a
background in cardiology, many of the laboratory-oriented
clinical investigators had roots in metabolism, and most of the
laboratory scientists had roots in physiology or biochemistry.
The giant personality I knew best during this period was my
mentor, Homer Smith, a physiologist, but intensely interested
in human kidney disease. He explored every facet of the
evolutionary basis for saying, "We are what we are because of
the kind of kidneys we have." Homer Smith thus helped give
nephrology a philosophical base, without which new medical
disciplines soon become shallow. By developing a system of
accurate and quantitative clearance techniques and physiologic
analyses, he and his cohorts helped place us in the main stream
of human biology. They helped give nephrology a hard scien-
tific base without which a new discipline might have become
too philosophical.
With this beginning we might ask quo vadimus nunc, or
where are we going now with the modern diagnostic develop-
ments that bring us our patients and stamp our specialty of
nephrology as an advancing one.
I would first cite immunonephrology as the cutting edge of
recent advances. Only a few years ago, simple immunofluores-
cence microscopy brought a new dimension to morphology;
IgG, 1gM, IgA, complement and fibrin products were tracked
through the natural history of particular disease states. New
diseases such as the IgA nephropathy or Berger disease
emerged from these technical advances. Further studies united
it, in turn, with the full spectrum of Schoenlein-Henoch purpu-
ra, one of Osler's favorite diseases, reborn in IgA. This finding
proved to be but a humble beginning.
In 1968, Dixon outlined two ways in which antibodies can
produce injury to the glomerulus. One from antibodies against
basement membrane, anti-GBM disease with its linear staining
as seen in Goodpasture syndrome and in some cases of rapidly
progressive glomerulonephritis. In a second form of injury,
antibodies to non-glomerular antigens form circulating immune-
complexes which could be trapped in the glomerulus depending
on such variables as complex size, vascular permeability, BP,
turbulence, state of the phagocytic system, valence or charge of
the antigen, complement fixability, and so forth. This mecha-
nism seems operative in only a minor fraction of clinical
disease.
Improved techniques, such as the Raja cell and the solid
phase Clq assays, have allowed the identification of antigen and
complexes in human glomerulonephritis. These antigens have
included the exogenous such as drugs, allergens, products of
bacteria, mycoplasmal, viral, protozoan, and fungal infections,
as well as endogenous antigens such as DNA in lupus and tumor
antigens in a variety of neoplasms.
The removal rates of immune complexes depend on small or
large lattice formation, the nature of antigen and antibody, and
the saturation of the monocytic phagocytic system. The mesan-
gium has emerged unlike a structural skeleton on which to hang
capillaries but like an active recycling factory for large, immune
reactants and high molecular weight proteins.
A C3 receptor has been identified on the epithelial cell of the
human glomerulus. The C3 receptors are on the wrong side of
the GBM for vascular deposition of immune complexes which
also can occur in complement-depleted animals. But they are on
the right side of the capillary membrane for ureteric reflux
antigens, and in transplant recipients, focal glomerular sclerosis
has been associated with ureteric reflux. Evidence also exists to
demonstrate specific receptor sites for the Fc fragment of IgG in
the interstitium of man and animals. Such sites may be involved
in the deposition of immune complexes in the renal interstitium
and may thus explain the immunologically mediated form of
interstitial nephritis.
Wilson's sensitive assays have shown that in some human
immune-complex nephritis, there is no unusual amount of
circulating complexes, suggesting that host or genetic factors
may play a role in the nephritogenesis from normal complexes.
He has also developed models for the nephritogenic potential of
antibodies directly reacting to structural antigens in the glomer-
ulus or planted there by previous injection. This constitutes in
situ complex formation. We know, of course, that antibodies
can also develop in response to previously deposited immune
complexes.
Mediator systems to produce injury from complex deposition
have now been identified in the complement cascade, in poly-
morphonuclear leukocytes, in monocytes or macrophages, in
platelet vasoactive-amines, and in a variety of kinin systems.
The use of an antimacrophage serum can abrogate histologic
changes and proteinuria in the serum sickness model in rabbits.
Epithelial cells are emerging from the frozen structural image
embraced in the term "podocyte." They have been shown to
make type 4 collagen, to secrete hippuran sulphate, chondroitin
sulphate, laminin, fibronectin, and to become feverishly active
when exposed to varied stimuli in fresh tissue cultures of
glomeruli.
The ability to separate T cells from B cells has led to
improved knowledge of specific T and B cell diseases and their
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role in transplantation. It is possible to immunostain the urine
by using rosette formation. By determining the percentage of B
cells in the lymphocytic population in the urine, it is perhaps
possible to distinguish infection from rejection in transplant
recipients and to predict which rejection reactions are easily
reversible, and which will have an outcome fatal to the graft.
In a paper to be presented at this meeting it was shown that
the kidney, in fact, constitutes a complete immune system.
Classically, antigen must be processed by mononuclear phago-
cytes before it can activate T cells. To stimulate T cells it is
mandatory that T cells interact with the I locus. Once-stimulat-
ed T cells then recruit and activate monocytes from the
peripheral circulation. Harvard investigators have demonstrat-
ed a sub-population of glomerular cells that are Ia positive.
They are in the mesangium; they are phagocytic in vitro and in
vivo; and they adhere to glass surfaces and interact with T cells
in a genetically controlled way. The human renal glomerulus
thus appears to be capable of functioning as an organ of immune
regulation. The mesangium appears to be able to process
antigen for presentation for helper or suppressor T lympho-
cytes, thereby initiating a nephro-centric immune response.
Thereafter, monocyte recruitment from the circulation may
result from the influx of cells resembling endothelial cell nuclei
on light microscopy. For whatever teleologic purpose, the
kidney seems to play the role of an auxillary line to immunolog-
ic surveillance and could be the prime mover in transplant
rejection. The mesangium can process antigen and proceed to a
cell-mediated reaction all by itself. In certain models of glomer-
ulonephritis a significant fraction of the proliferative cells
resembling endothelial cell nuclei are actually monocytes re-
cruited from the circulation.
Lastly, the hormonal or humoral functions of the kidney are
merging with the immunologic formation system. Leukotrienes
can influence virtually all the events of classic inflammation.
The new mesangial cell may produce prostaglandin. Also, it has
been demonstrated that collagen can stimulate the production
of mononuclear cell factor and prostaglandin PGE2 by human
monocytes.
The second area I will address is that of hormones. The
concept of the kidney as an endocrine organ has broadened
enormously. One group of true hormones as secreted by the
kidney and acts at extra-renal sites. Erythropoietin, renin, and
1,25-dihydroxy vitamin D are examples. Erythropoietin ex-
plains the erythrocytosis of polycystic kidney disease and renal
adenocarcinoma.
The kidney has assumed a central role in the control of BP
with its renin-angiotensin, aldosterone system on the pressor
side, and kallikreinkinin-phospholipase or arachidonic acid
system on the depressor side. Through angiotensin II the
kidney indirectly impinges on many fundamental mechanisms
including thirst, ganglionic stimulation, catecholamine release,
and on inotropic action on the heart.
But the greatest explosion has been the prostaglandin system
which may someday be classified as the master chemist of the
kidney. Leukotrienes made by lipo-oxygenase from arachidonic
acid may be more leukotaxic than complement and are capable
of inducing many of the events we have associated with
inflammation. Renal blood flow is enhanced by the vasodilators
PGE2. The same agents increase and decrease the GFR. PGI2,
PGE2, and PGD2 stimulate renal secretion; thromboxane may
decrease it. The same three are natriuretic, and PGE2 is water
diuretic. Thromboxane is probably involved in a variety of renal
injuries such as eclampsia, DIC, sepsis, and the hemolytic
uremic syndrome. We have found that the breakdown product
of thromboxane, immunoreactive TXB2 excretion, to be a most
sensitive index of transplant rejection. Its rise precedes 132
microglobulin excretion and other early indicators. Thus, ara-
chidonic acid through cyclo-oxygenase produces a whole family
of regulatory molecules affecting the discrete functions of the
kidney. The fact that granulocytes, monocytes, phagocytes,
and cells derived from them, including some mesangial cells,
juxtaglomerular cells, and other kidney cells, are all active
producers of prostaglandins suggest that this is a rather funda-
mental biology and that the varied histologic responses to
specific diseases may have functional sequellae mediated
through the arachidonic hormones.
The kidney, of course, is the key regulator of calcium and
phosphorus. It can metabolize 25-hydroxy vitamin D3 into 1,25-
dihydroxycholecalciferol, the most active known form of D3,
which is 10 times more effective in curing rickets and 100 times
more potent than 25-hydroxy D3 in mobilizing calcium from
bone. This product is activated by an increase in parathyroid
hormone and a decrease in phosphate. When both of those are
normal, then the 24,25-hydroxy D3 prevails. The kidney thus
interacts in a central way with parathyroid hormone. Renal
failure can result in an excess of parathyroid hormone with its
toxic trail winding through many membranes and tissues of the
body and possibly explaining some aspects of uremic toxicity.
The natriuretic hormone can indirectly influence intracellular
calcium. De Wardner has implicated the natriuretic hormone in
the pathogenesis of essential hypertension while Bricker feels it
may account for some features of uremic toxicity.
The third area of diagnostic development has been in the
matter of a tremendous outpouring of new techniques for
imaging. These techniques have already changed the face of
clinical medicine by permitting a much earlier diagnosis of
space occupying lesions, helping to differentiate cysts from
tumors, and preventing the morbidity and mortality of explor-
atory surgery.
Ultrasound has made possible the differentiation between
single and multiple cysts and has provided a non-invasive
screening technique whereby an entire family tree can be
surveyed to provide fresh genetic and epidemiologic insights
into the ancient questions we have long posed about polycystic
kidney disease. It is possible to pick up lesions in children, to
visualize liver cysts at the same time, and to have ultrasound
serve as a guidance system for diagnostic puncture and thera-
peutic deflation of larger cysts producing obstruction. Simple
sodium analysis of the aspirated cyst fluid can distinguish
proximal from distal cysts. Cyst fluid can be analyzed for
hormones, enzymes, and biologically active amines. Selective
angiography can precisely diagnose the cause and site of renal
vascular hypertension and distinguish vascular and extrinsic
lesions from neoplasms. Computer-assisted tomography, CAT
scans, allow even earlier recognition of cysts and tumors,
metastatic lesions, and calculi. In one study of 11 consecutive
patients with hyperkalemia, hyperaldosteronism, and elevated
18 hydroxycorticosterone levels, unilateral masses were shown
in the adrenal gland; adenomas were then found during surgery
to explain the primary aldosteronism. Computerized tomogra-
phy can reliably find tumors down to one cm in diameter.
Micturating cine-cystography has shed new light on function-
al and structural abnormalities of the pelvis and ureter; vesical
hypertrophy, and vesico ureteric reflux. Technetium scans
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have ascertained blood flow in oliguric transplants and allow us
to differentiate from the ischemic diseases. Gallium scanning
has confirmed inflammation in drug-induced interstitial nephrit-
ides, lipoid nephrosis, and other causes of interstitial inflamma-
tion. A variety of other isotope scans are available for imaging
in a host of less common diseases. We have entered into a
period where both the surgeon and the nephrologist can narrow
the differential diagnosis in most space-occupying lesions,
invade the body only when necessary, and know in advance
with virtual certainty what and where the pathology will be
found.
The fourth area of progress I would term downstream analy-
ses. In addition to the traditional metabolite used in clearance
methodology and identification of light chains to differentiate
the monoclonal gammopathies, modern nephrology has ex-
panded in the field of downstream analyses to diagnose up-
stream events. 132 microglobulin elevation can distinguish cysti-
tis from renal infection as well as impending acute tubular
necrosis due to drugs; it has proven to be a sensitive and early
marker for transplant rejection. However, microglobulins have
hardly taken their rightful clinical place when we now find that
thromboxane or TXB2 excretion in urine is an even more
sensitive index and precedes in time the elevation of 132 micro-
globulins in transplant rejection.
Beta-glucuronidase has been found elevated in diseases nota-
ble for tubular disruption. A 250% increase in beta-glucuroni-
dase activity was noted after cis-platinum therapy for neoplasms.
This degree of tubular toxicity could not be measured by any of
the usual indexes of renal function. Studies of N-acetyl-beta-
glucocidase and alanine-aminopeptidase have shown that enzy-
muria correlates with the severity of ischemic acute renal failure,
has predictive value for the outcome, and is useful in clinical
management.
Urinary eosinophilia occurs in two-thirds of drug-induced
interstitial nephritides. Platelets have also been identified in
urine. Immunofluorescence has identified all common serum
proteins in the granules of granular casts and Tamm Horsfall
protein in the matrix. Urinary LDH has been found elevated
independently of serum LDH in relapsed nephrotic syndrome.
Glycolipid in the sediment is a marker for Fabry disease or
angiokeratoma corporus diffusum. The urine continues to be an
inexhaustible source of evidence for upstream events. It is a
slate upon which we can read the events in the nephron which
formed it.
Finally, I will speak briefly about cell biology. Physiology has
rapidly moved from organ-centered research through the micro-
puncture era centered on nephrons to cell biology. An elegant
tissue culture of tubular cells permits in vitro exploration of in
vivo functions and will enable the rapid screening of hormones,
humoral agents, drugs, and poisons for their stimulative and
inhibitive effects on tubular transport.
T cells, B cells, helper cells, suppressor cells, activated
monocytes, and now even mesangial cells are being studied for
motility adherence, surface receptors, membrane function,
production of a host of proteins as well as prostaglandins and
their genetic markers. As we have seen, glomerular culture has
already yielded positive results in the identification of 100
macrophages/glomerulus at the height of a serum sickness
reaction.
Local gene effects can be studied by recombinant DNA
techniques and genetic engineering; it is not too futuristic to
envision a one cell, one disease, medical world in the foresee-
able future.
In conclusion, each one of you will know some advances that
I have not cited, however, it is important to remember that most
of the ones which I have cited came from developments in the
basic sciences or in other disciplines. Nephrology, thank God,
has traditionally been outbred and pluralistic. Founded on
physiology, bacteriology and immunology, metabolism and
biochemistry, it has remained ever alert to new developments in
both the physical and biological sciences. As a result, we have
an exciting week ahead of us in Athens as we catch up on the
vast ocean of modern nephrology. Like the Greeks of the 10
thousand when they returned from the Persian Wars and beheld
the sea, nephrologists the world over join me this week in
saying "Thalassa Thalassa."
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